ASSOCIATIONS BETWEEN HBA1C LEVELS AND LIVER FUNCTION TESTS IN DIABETES: A COMPREHENSIVE ANALYSIS

JOSEPH KI; SIVAGAMI K; MOHAN KUMAR; APARNAVI P; JEEVITHAN S

doi:10.22159/ajpcr.2024v17i12.52050

Authors

JOSEPH KI Department of General Medicine, KMCHIHSR, Coimbatore, Tamil Nadu, India
SIVAGAMI K Department of Community Medicine, KMCHIHSR, Coimbatore, Tamil Nadu, India.
MOHAN KUMAR Department of Community Medicine, KMCHIHSR, Coimbatore, Tamil Nadu, India.
APARNAVI P Department of Community Medicine, KMCHIHSR, Coimbatore, Tamil Nadu, India.
JEEVITHAN S Department of Community Medicine, KMCHIHSR, Coimbatore, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2024v17i12.52050

Keywords:

Hemoglobin A1c, Liver function tests, Master health check-up;, Diabetes mellitus, Tamil Nadu

Abstract

Objective: To determine the liver function tests status among the diabetic patients. Diabetes mellitus (DM) is a chronic multi-system disease characterized by hyperglycemia. The most common type of DM, Type 2 DM (T2DM), is characterized by insulin resistance and insufficient insulin secretory response. T2DM is frequently associated with abnormal liver function tests (LFTs). Our study aims to widen our knowledge of the complex interrelationship between T2DM and LFTs.

Methodology: This study was done in a multi-specialty hospital in Western part of Tamil Nadu among the patients who came for master health check-up between 2017 and 2024. From the laboratory database of 67,000 patients, patients who reported for the 1st time and had their hemoglobin A1c (HbA1c) and LFT values evaluated were selected. They were categorized as normal, pre-diabetic, and diabetic based on HbA1c values. Data were analyzed using SPSS 27. Categorical variables were expressed in the form of frequency and percentages whereas continuous variables were expressed in the form of mean and standard deviation. Analysis of variance (ANOVA) was used to find out any significant difference in lipid profile among the three groups.

Results: Our study had 23,238 participants. Out of them 7168 (30.84%) had normal HbA1c levels, 8347 (35.91%) were pre-diabetics and 7955 (34.23%) were diabetic patients. The mean total protein (TP), serum glutamic-pyruvic transaminase (SGPT), and alkaline phosphatase (ALP) were higher among the diabetic patients. ANOVA showed that there was a significant difference in serum total bilirubin, TP, albumin, serum glutamic-oxaloacetic transaminase (SGOT), SGPT, and ALP between the three groups. Pearson correlation coefficient showed a positive correlation between SGOT, SGPT, ALP, and HbA1c. It showed a negative correlation between TB, albumin, and HbA1c.

Conclusion: From the findings of this study, there is evidence that there exists a significant association between HbA1c levels and LFTs. Elevated HbA1c levels correlate with abnormal LFT results, suggesting a potential link between glycemic control and liver health. These results underscore the need for monitoring both HbA1c and LFTs in patients with diabetes to manage their overall health comprehensively.

Downloads

Download data is not yet available.

References

American Diabetic Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31 Suppl 1:S62-7. doi: 10.2337/ dc14-S081

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53. doi: 10.2337/diacare.27.5.1047, PMID 15111519

Burtis CA, Ashwood ER, Bruns DE. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 5th ed. London, England: W. B. Saunders; 2012.

Leevy CM, Ryan CM, Fineberg JC. Diabetes mellitus and liver dysfunction; etiologic and therapeutic considerations. Am J Med. 1950;8(3):290-9. doi: 10.1016/0002-9343(50)90062-3, PMID 15404972

Salmela PI, Sotaniemi EA, Niemi M, Mäentausta O. Liver function tests in diabetic patients. Diabetes Care. 1984;7(3):248-54. doi: 10.2337/ diacare.7.3.248, PMID 6734394

Harris EH. Elevated liver function tests in type 2 diabetes. Clin Diabetes. 2005;23(3):115-9. doi: 10.2337/diaclin.23.3.115

Saligram S, Williams EJ, Masding MG. Raised liver enzymes in newly diagnosed type 2 diabetes are associated with weight and lipids, but not glycaemic control. Indian J Endocrinol Metab. 2012;16(6):1012-4. doi: 10.4103/2230-8210.103027, PMID 23226654

Ni H, Soe HH, Htet A. Determinants of abnormal liver function tests in diabetes patients in Myanmar. Int J Diabetes Res. 2012;1:36-41. doi: 10.5923/j.diabetes.20120103.02

Forlani G, Di Bonito P, Mannucci E, Capaldo B, Genovese S, Orrasch M, et al. Prevalence of elevated liver enzymes in type 2 diabetes mellitus and its association with the metabolic syndrome. J Endocrinol Invest. 2008;31(2):146-52. doi: 10.1007/BF03345581, PMID 18362506

Kocabay G, Telci A, Tutuncu Y, Tiryaki B, Ozel S, Cevikbas U, et al. Alkaline phosphatase: Can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes? Bratisl Lek Listy. 2011;112(11):626-9. PMID 22180989

Villegas R, Xiang YB, Elasy T, Cai Q, Xu W, Li H, et al. Liver enzymes, type 2 diabetes, and metabolic syndrome in middle-aged, urban Chinese men. Metab Syndr Relat Disord. 2011;9(4):305-11. doi: 10.1089/met.2011.0016, PMID 21495862

Succurro E, Arturi F, Grembiale A, Iorio F, Fiorentino TV, Andreozzi F, et al. One-hour post-load plasma glucose levels are associated with elevated liver enzymes. Nutr Metab Cardiovasc Dis. 2011;21(9):713-8. doi: 10.1016/j.numecd.2011.02.002, PMID 21764272

Zhang Y, Lu X, Hong J, Chao M, Gu W, Wang W, et al. Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus. Endocrine. 2010;38(2):181-7. doi: 10.1007/s12020-010-9369-6, PMID 20972737

Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Tanizaki Y, et al. Liver enzymes as a predictor for incident diabetes in a Japanese population: The Hisayama study. Obesity (Silver Spring). 2007;15(7):1841-50. doi: 10.1038/oby.2007.218, PMID 17636103

Abbasi A, Bakker SJ, Corpeleijn E, van der AD, Gansevoort RT, Gans RO, et al. Liver function tests and risk prediction of incident type 2 diabetes: Evaluation in two independent cohorts. PLoS One. 2012;7(12):e51496. doi: 10.1371/journal.pone.0051496, PMID 23284703

Kunutsor SK, Apekey TA, Walley J. Liver aminotransferases and risk of incident type 2 diabetes: A systematic review and meta-analysis. Am J Epidemiol. 2013;178(2):159-71. doi: 10.1093/aje/kws469, PMID 23729682

Schulze MB, Weikert C, Pischon T, Bergmann MM, Al-Hasani H, Schleicher E, et al. Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: The EPIC-Potsdam Study. Diabetes Care. 2009;32(11):2116-9. doi: 10.2337/dc09-0197, PMID 19720844

Nazki FA, Syyeda A, Mohammed S. Total proteins, albumin and HbA1c in type 2 diabetes mellitus. MedPulse. 2017;3:1-5.

Gul A, Rahman MA. Comparison of blood protein levels between diabetic and non-diabetic patients with retinopathy. J Coll Physicians Surg Pak. 2006 Jun;16(6):408-11. PMID 1678761820. Calanna S, Scicali R, Di Pino A, Knop FK, Piro S, Rabuazzo AM, et al. Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes. Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):670-6. doi: 10.1016/j.numecd.2014.01.013, PMID 24656139

Chilay A, Mehra N, Misra M, Jatale R, Ramchandran S. Liver function test and diabetes mellitus: Correlation from a laboratory perspective. Indian J Med Biochem. 2023;27(2):40-4. doi: 10.5005/jp-journals-10054-0220

Jha SK, Yadav NK, Rizal S. Prevalence of elevated liver enzymes and its association with type 2 diabetes: A descriptive cross-sectional study among Nepalese adults from Biratnagar, Nepal. Asian J Med Sci. 2021;12(6):50-5. doi: 10.3126/ajms.v12i6.37074

Kadi H, Ceyhan K, Sogut E, Koc F, Celik A, Onalan O, et al. Mildly decreased glomerular filtration rate is associated with poor coronary collateral circulation in patients with coronary artery disease. Clin Cardiol. 2011;34(10):617-21. doi: 10.1002/clc.20951, PMID 21887692

Levy AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. Modification of diet in renal disease study group. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann J Med. 1999;130:461-70. doi: 10.7326/0003-4819-130- 6-199903160-00002

Westerbacka J, Cornér A, Tiikkainen M, Tamminen M, Vehkavaara S, Häkkinen AM, et al. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: Implications for sex differences in markers of cardiovascular risk. Diabetologia. 2004;47(8):1360-9. doi: 10.1007/s00125-004-1460-1, PMID 15309287

Zhang Y, Zhou C, Li J, Zhang Y, Xie D, Liang M, et al. Serum alkaline phosphatase levels and the risk of new-onset diabetes in hypertensive adults. Cardiovasc Diabetol. 2020 Oct 24;19(1):186. doi: 10.1186/ s12933-020-01161-x, PMID 33099298

Azpiazu D, Gonzalo S, Villa-Bellosta R. Tissue non-specific alkaline phosphatase and vascular calcification: A potential therapeutic target. Curr Cardiol Rev. 2019;15(2):91-5. doi: 10.2174/1573403X146661810 31141226, PMID 30381085

Fadini GP, Pauletto P, Avogaro A, Rattazzi M. The good and the bad in the link between insulin resistance and vascular calcification. Atherosclerosis. 2007;193(2):241-4. doi: 10.1016/j. atherosclerosis.2007.05.015, PMID 17606264

Bouvet C, Peeters W, Moreau S, DeBlois D, Moreau P. A new rat model of diabetic macrovascular complication. Cardiovasc Res. 2007;73(3):504-11. doi: 10.1016/j.cardiores.2006.11.001, PMID 17145050

House LM 2nd, Morris RT, Barnes TM, Lantier L, Cyphert TJ, McGuinness OP, et al. Tissue inflammation and nitric oxide-mediated alterations in cardiovascular function are major determinants of endotoxin-induced insulin resistance. Cardiovasc Diabetol. 2015;14:56. doi: 10.1186/s12933-015-0223-2, PMID 25986700

Schultz-Hector S, Balz K, Böhm M, Ikehara Y, Rieke L. Cellular localization of endothelial alkaline phosphatase reaction product and enzyme protein in the myocardium. J Histochem Cytochem. 1993;41(12):1813-21. doi: 10.1177/41.12.8245430, PMID 8245430

Boo YC, Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: Role of protein kinases. Am J Physiol Cell Physiol. 2003;285(3):C499-508. doi: 10.1152/ajpcell.00122.2003, PMID 12900384

Tiwari S, Bothale M, Hasan I, Kulkarni MJ, Sayyad MG, Basu R, et al. Association between serum albumin and glycated hemoglobin in Asian Indian subjects. Indian J Endocrinol Metab. 2015 Feb;19(1):52-5. doi: 10.4103/2230-8210.144631, PMID 25593826

Feng X, Yang Y, Zhuang S, Fang Y, Dai Y, Fu Y, et al. Influence of serum albumin on HbA1c and HbA1c-defined glycemic status: A retrospective study. Front Med (Lausanne). 2021 May 12;8:583093. doi: 10.3389/fmed.2021.583093, PMID 34055818

Choi SW, Lee YH, Kweon SS, Song HR, Ahn HR, Rhee JA, et al. Association between total bilirubin and hemoglobin A1c in Korean type 2 diabetic patients. J Korean Med Sci. 2012 Oct;27(10):1196-201. doi: 10.3346/jkms.2012.27.10.1196, PMID 23091317

Mylonas C, Kouretas D. Lipid peroxidation and tissue damage. In Vivo. 1999;13(3):295-309. PMID 10459507.

Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421-31. doi: 10.7326/0003-4819-141-6-200409210-00007, PMID 15381515

Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23 Suppl 2:B21-9. PMID 10860187

Vítek L, Jirsa M, Brodanová M, Kalab M, Marecek Z, Danzig V, et al. Gilbert syndrome and ischemic heart disease: A protective effect of elevated bilirubin levels. Atherosclerosis. 2002;160(2):449-56. doi: 10.1016/s0021-9150(01)00601-3, PMID 11849670